Medicine and Dentistry
Patient
100%
Malignant Neoplasm
55%
Inpatient
52%
Breast Cancer
42%
Head and Neck Squamous Cell Carcinoma
41%
Disease
32%
Combination Therapy
26%
Immune Checkpoint Inhibitor
25%
Chemotherapy
24%
Overall Survival
21%
Hospital
19%
Diagnosis
18%
Metastatic Carcinoma
17%
Neoplasm
17%
Cancer Cell
15%
Case Report
14%
Hazard Ratio
14%
Prognosis
13%
Neck
12%
Follow up
12%
Surgery
11%
Cisplatin
11%
Gene
11%
Gamma Urogastrone
11%
Epidermal Growth Factor Receptor 2
11%
Chemoradiotherapy
10%
Analysis
10%
Cells
10%
Ascorbic Acid
10%
Retrospective Cohort Study
10%
Lymph Node Metastasis
10%
Supraclavicular Lymph Node
10%
Cancer Research
10%
Gefitinib
10%
Stomach Adenocarcinoma
10%
Germinoma
10%
Head
10%
Biliary Tract Cancer
10%
Endodermal Sinus Tumor
10%
Patient with Cancer
10%
Squamous Cell Carcinoma
10%
Breast Carcinoma
10%
Non Small Cell Lung Cancer
10%
Organizing Pneumonia
10%
Age
9%
Cancer Therapy
9%
Stomach
9%
Acute Myeloid Leukemia
8%
Female
8%
Progression Free Survival
7%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
62%
Stomach Cancer
26%
Head and Neck Squamous Cell Carcinoma
25%
Chemotherapy
23%
Neoplasm
22%
Diseases
21%
Gefitinib
20%
Non Small Cell Lung Cancer
20%
Capecitabine
20%
Breast Cancer
16%
Overall Survival
16%
Tamoxifen
16%
Metastatic Breast Cancer
15%
Paclitaxel
15%
Catenin
15%
Biological Marker
13%
Palbociclib
12%
Fluorouracil
12%
Progression Free Survival
11%
Hormone Receptor
11%
Combination Therapy
10%
Exemestane
10%
Chronic Myeloid Leukemia
10%
Pancreas Cancer
10%
Rheumatoid Arthritis
10%
Imatinib
10%
Gemcitabine
10%
Tolerability
10%
Nintedanib
10%
Salivary Gland Cancer
10%
Ascorbic Acid
10%
Monotherapy
10%
Etanercept
10%
Pneumonia
10%
Hepatotoxicity
10%
Death
8%
Toxicity
8%
Adverse Event
6%
Survival Rate
5%
Survival
5%
Epidermal Growth Factor Receptor Kinase Inhibitor
5%
Neutropenia
5%
Reactive Oxygen Metabolite
5%
Drug
5%
Arsenite
5%
Trastuzumab
5%
Peroxiredoxin 3
5%
Promyelocytic Leukemia
5%
Apoptosis
5%
Gonadorelin Agonist
5%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
25%
Mutation
19%
Circulating Tumor DNA
16%
Sequencing
16%
Catenin
15%
Nested Gene
11%
Progression Free Survival
10%
CD44
10%
Gefitinib
10%
Ascorbic Acid
10%
Overall Survival
9%
Sample
8%
Lysozyme
7%
Gene Mutation
6%
Gene Expression
5%
Small Molecule
5%
Receptor Tyrosine Kinase Inhibitors
5%
Topoisomerase
5%
Exon
5%
Imatinib
5%
Arsenic Trioxide
5%
Tau Protein
5%
Peroxiredoxin
5%
Tumor Gene
5%
Species
5%
Genotyping
5%
Myeloid
5%
Apoptosis
5%
